Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Child neurodevelopment is related to maternal manganese exposure: A Taiwan national prospective cohort study.

Ecotoxicology and environmental safety·2026
Same author

Predictive validity of the personal and social performance scale for PANSS outcomes in schizophrenia: a severity-stratified study.

BMC research notes·2026
Same author

The clinical utility of the immune status questionnaire as a marker of immune function among persons with schizophrenia.

Science progress·2025
Same author

Long-term anxiety of natural and biological hazards on community and healthcare workers.

Frontiers in psychiatry·2025
Same author

Psychometric evaluation of a patient- and caregiver-rated early warning signs scale for acute exacerbations in schizophrenia.

BMC psychiatry·2025
Same author

Potential role of calcium sulfate/β-tricalcium phosphate/graphene oxide nanocomposite for bone graft application_mechanical and biological analyses.

Journal of orthopaedic surgery and research·2024

Related Experiment Video

Updated: May 26, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

p53 codon 72 polymorphism as a progression index for bladder cancer.

Hung-Yu Lin1, Chun-Hsiung Huang, Tsan-Jung Yu

  • 1Department of Urology, E-DA Hospital/I-SHOU University, Kaohsiung, Taiwan, ROC.

Oncology Reports
|December 28, 2011
PubMed
Summary

The p53 codon 72 Pro/Pro genotype is linked to bladder cancer progression, not initial development. This genotype shows a high negative predictive value (NPV) for invasive tumors, suggesting its clinical utility as a bladder cancer progression index.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Related Experiment Videos

Last Updated: May 26, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Area of Science:

  • Genetics and Oncology
  • Molecular Biology
  • Cancer Biomarkers

Background:

  • The p53 codon 72 polymorphism is a common genetic variation.
  • Its role in bladder cancer incidence and progression requires further elucidation.
  • Accurate bladder cancer management indices are crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the positive predictive value (PPV) and negative predictive value (NPV) of p53 codon 72 genotypes.
  • To determine if p53 codon 72 can serve as a bladder cancer management index.
  • To assess the association of p53 codon 72 polymorphism with bladder cancer incidence, grade, invasiveness, recurrence, and survival.

Main Methods:

  • Case-control study including 96 bladder cancer patients and 569 controls.
  • Logistic regression analysis adjusted for age and gender.
  • Cox regression analysis for tumor recurrence and cancer-related death.

Main Results:

  • The Pro/Pro genotype was not significantly associated with bladder cancer incidence.
  • Pro/Pro genotype strongly correlated with muscle-invasive tumors (P=0.002), with a 3.36-fold increased risk.
  • The Pro/Pro genotype demonstrated a high NPV (88.00%) for invasive tumors and was associated with cancer-related death (OR=2.87).

Conclusions:

  • p53 codon 72 polymorphism influences bladder cancer progression, not incidence or prognosis.
  • The Pro/Pro genotype exhibits a high NPV for bladder cancer progression.
  • The Pro/Pro genotype can be clinically utilized as a progression index in bladder cancer management.